wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37994555-2CFE8E9B-448F-4CE8-AFE3-C9EE9C29A3CE
Q37994555-2CFE8E9B-448F-4CE8-AFE3-C9EE9C29A3CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37994555-2CFE8E9B-448F-4CE8-AFE3-C9EE9C29A3CE
Emerging disease-modifying therapies in multiple sclerosis.
P2860
Q37994555-2CFE8E9B-448F-4CE8-AFE3-C9EE9C29A3CE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37994555-2CFE8E9B-448F-4CE8-AFE3-C9EE9C29A3CE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8607579108eed637ad7e23f5bf4e5cd987265975
P2860
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.